NDC 63629-8260

INVOKAMET

Canagliflozin And Metformin Hydrochloride

INVOKAMET is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Canagliflozin; Metformin Hydrochloride.

Product ID63629-8260_47bc5f2e-dde5-45d0-bee8-44ce9581cec3
NDC63629-8260
Product TypeHuman Prescription Drug
Proprietary NameINVOKAMET
Generic NameCanagliflozin And Metformin Hydrochloride
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2014-08-08
Marketing CategoryNDA /
Application NumberNDA204353
Labeler NameBryant Ranch Prepack
Substance NameCANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Active Ingredient Strength150 mg/1; g/1
Pharm ClassesSodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Biguanide [EPC],Biguanides [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 63629-8260-1

30 TABLET, FILM COATED in 1 BOTTLE (63629-8260-1)
Marketing Start Date2014-08-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "INVOKAMET" or generic name "Canagliflozin And Metformin Hydrochloride"

NDCBrand NameGeneric Name
50458-540INVOKAMETcanagliflozin and metformin hydrochloride
50458-541INVOKAMETcanagliflozin and metformin hydrochloride
50458-542INVOKAMETcanagliflozin and metformin hydrochloride
50458-543INVOKAMETcanagliflozin and metformin hydrochloride
63629-8260INVOKAMETcanagliflozin and metformin hydrochloride
50458-940INVOKAMET XRcanagliflozin and metformin hydrochloride
50458-941INVOKAMET XRcanagliflozin and metformin hydrochloride
50458-942INVOKAMET XRcanagliflozin and metformin hydrochloride
50458-943INVOKAMET XRcanagliflozin and metformin hydrochloride

Trademark Results [INVOKAMET]

Mark Image

Registration | Serial
Company
Trademark
Application Date
INVOKAMET
INVOKAMET
85857070 4629331 Live/Registered
JOHNSON & JOHNSON
2013-02-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.